ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
Multicentre, Prospective, Open Clinical Study of Postoperative ctDNA Dynamic Monitoring and Its Role of Prognosis in Patients With Stage I Non-small Cell Lung Cancer (NSCLC) Using Secondary Gene Sequencing (NGS)
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
A observational or N/A phase clinical study on Non-small Cell Lung Cancer Stage I, this trial is completed. The trial is conducted by First Affiliated Hospital, Sun Yat-Sen University and has accumulated 13 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Oct 2024 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Feb 2020 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Aug 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital, Sun Yat-Sen University
- Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .